Ready-to-use liquids are commonly used in the manufacturing process of mAb, cell & gene therapy, and other novel modalities. They increase the process efficiency, minimize the need for floorspace, and eliminate non-value-added steps from your process. Our new catalog portfolio, Liquid Solutions MyWay, which includes the most common sterile filtered liquids, provides more flexibility and reduces the lead time (compared to customized products) with no compromise on quality. Can’t wait to learn more? Join our webinar.
In this webinar, you will learn about:
- Trends of ready-to-use liquids
- Our new catalog portfolio
- Benefits and advantages of Liquid Solutions MyWay
- Target applications for your process
Speaker
Sadao Ozawa, Ph.D.
MilliporeSigma
Senior Customer Application Specialist
Dr. Sadao Ozawa is a senior upstream customer application specialist in the process solutions division of MilliporeSigma. He is based in Tokyo and has been with the company for 26 years. Recently, he has supported the Japanese upstream process development and manufacturing as well as the market development of cell and gene therapy. He holds a Ph.D. from the Science University of Tokyo in biochemical engineering.
Pharma and biopharma manufacturing
- Cell therapy manufacturing
Duration:1hr
Language:English
Session 1:presented September 13, 2022
To continue reading please sign in or create an account.
Don't Have An Account?